AU4486501A - High dosage parenteral administration of lactoferrin - Google Patents

High dosage parenteral administration of lactoferrin

Info

Publication number
AU4486501A
AU4486501A AU44865/01A AU4486501A AU4486501A AU 4486501 A AU4486501 A AU 4486501A AU 44865/01 A AU44865/01 A AU 44865/01A AU 4486501 A AU4486501 A AU 4486501A AU 4486501 A AU4486501 A AU 4486501A
Authority
AU
Australia
Prior art keywords
lactoferrin
parenteral administration
high dosage
dosage parenteral
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU44865/01A
Inventor
Johannes Henricus Nuijens
Johannes Bernardus Mathias Marie Van Bree
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharming Intellectual Property BV
Original Assignee
Pharming Intellectual Property BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharming Intellectual Property BV filed Critical Pharming Intellectual Property BV
Publication of AU4486501A publication Critical patent/AU4486501A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU44865/01A 2000-03-27 2001-03-27 High dosage parenteral administration of lactoferrin Abandoned AU4486501A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US19335200P 2000-03-27 2000-03-27
EP00201110 2000-03-27
EP00201110 2000-03-27
US60193352 2000-03-27
PCT/NL2001/000253 WO2001072322A2 (en) 2000-03-27 2001-03-27 High dosage parenteral administration of lactoferrin

Publications (1)

Publication Number Publication Date
AU4486501A true AU4486501A (en) 2001-10-08

Family

ID=26072048

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44865/01A Abandoned AU4486501A (en) 2000-03-27 2001-03-27 High dosage parenteral administration of lactoferrin

Country Status (2)

Country Link
AU (1) AU4486501A (en)
WO (1) WO2001072322A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107304424A (en) * 2016-05-23 2017-10-31 成都福际生物技术有限公司 Transferrins DNA binding domain, recombinant DNA polymerase and the preparation method of transformation

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002077239A1 (en) * 2001-03-27 2002-10-03 Sumitomo Pharmaceuticals Company, Limited Hcv-binding polypeptides
EP1360961A1 (en) * 2002-05-07 2003-11-12 AM-Pharma B.V. Use of antimicrobial peptides for potentiating the activity of antimicrobial agents
WO2004052305A2 (en) 2002-12-10 2004-06-24 Agennix Incorporated Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease
WO2004089986A1 (en) * 2003-04-14 2004-10-21 Stichting Voor De Technische Wetenschappen Antimicrobial peptide from transferrin family
WO2004103285A2 (en) 2003-05-14 2004-12-02 Agennix Incorporated Lactoferrin in the treatment of diabetes mellitus
EP1653987A4 (en) * 2003-07-16 2006-08-09 Univ New York State Res Found Host defense factor x (hdfx)
WO2006047744A2 (en) 2004-10-26 2006-05-04 Agennix Incorporated Compositions of lactoferrin related peptides and uses thereof
ITMI20052351A1 (en) * 2005-12-09 2007-06-10 Microbo Srl NEW PHARMACEUTICAL USE OF TRANSFERRIN AND DERIVED PHARMACEUTICAL COMPOSITIONS
EP1993592A4 (en) * 2006-02-21 2011-11-16 Ventria Bioscience Compositions containing lactoferrin, and methods of using same to promote growth of skin cells
CA3104620A1 (en) * 2018-06-26 2020-01-02 S&K Biopharma, Inc. Glycosaminoglycan inhibitor and promoter
IT202000005011A1 (en) * 2020-03-09 2021-09-09 Sofar Spa Lactoferrin for oral use with antiviral action

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3645282B2 (en) * 1994-04-22 2005-05-11 森永乳業株式会社 Heparin neutralizer
AU2436095A (en) * 1994-05-05 1995-11-29 Ferrodynamics, Inc. Cloning, expression, and uses of human lactoferrin
JP3506274B2 (en) * 1994-09-01 2004-03-15 雪印乳業株式会社 New peptides and immunostimulants
US6333311B1 (en) * 1997-02-03 2001-12-25 Pharming Useful properties of human lactoferrin and variants thereof
ATE255130T1 (en) * 1997-09-16 2003-12-15 Wolf-Georg Forssmann BIFIDOGENE PEPTIDES AND THEIR USE
CA2388910C (en) * 1999-11-11 2008-10-07 Am-Pharma B.V. Antimicrobial activity of the first cationic cluster of human lactoferrin

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107304424A (en) * 2016-05-23 2017-10-31 成都福际生物技术有限公司 Transferrins DNA binding domain, recombinant DNA polymerase and the preparation method of transformation
CN107304424B (en) * 2016-05-23 2019-05-10 成都福际生物技术有限公司 Transferrins DNA binding domain, recombinant DNA polymerase and the preparation method of transformation

Also Published As

Publication number Publication date
WO2001072322A3 (en) 2002-03-21
WO2001072322A2 (en) 2001-10-04

Similar Documents

Publication Publication Date Title
AU2353701A (en) Transepithelial delivery of glp-1 derivatives
AU2002217980A1 (en) Conjugates of glycosylated/galactosylated peptide
AU2001250347A1 (en) Miniaturized needleless injector
AU2001238386A1 (en) Medication delivery devices
AU2705201A (en) Ceramic structure
AU6887401A (en) Delivery of remotely-ordered products
AU4486501A (en) High dosage parenteral administration of lactoferrin
AU2001284444A1 (en) Preparations for oral administration
AU2002360717A1 (en) Controlled release dosage form having improved drug release properties
SI1136081T1 (en) Sustained-release compositions for the parenteral administration of macrolides
AU777185C (en) Pharmaceutical form of administration for peptides, methods for its production and use
AU2001238346A1 (en) Modification of biopolymers for improved drug delivery
AU2002217229A1 (en) Pharmaceutical dronedarone composition for parenteral administration
IL155428A0 (en) Pharmaceutical dronedarone composition for parenteral administration
AU2002221099A1 (en) Combination drugs
AU6902901A (en) Synchronisation of databases
AU2001284763A1 (en) Preparation of risperidone
AU2692200A (en) Enteral sorbefacients
AU2002341555A1 (en) Levothyroxine pharmaceutical compositions, methods of making and methods of administration
AU2001232244A1 (en) Drug comprising combination
AU4085201A (en) Pharmaceutical composition
AU2001265280A1 (en) Preparation of 2-hydroxy-5-oxoproline and analogs thereof
AU4876701A (en) Peptide derivatives and medicinal compositions
AU1172101A (en) Phytoestrogenic pharmaceutical preparations
AU3586401A (en) Pharmaceutical composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase